摘要:
Nitroimidazolyl-s-triazolo(4,3-b)pyridazines of the formula: wherein R1 and R2 are, individually, hydrogen or a numbe organic radicals or, taken together, can be an alkylene bridge; AND R3 is hydrogen or lower alkyl; or, together with R2, R3 can form an alkylene bridge; N IS 0 OR 1; AND THE PHARMACEUTICALLY COMPATIBLE THEREOF, POSSESS HIGH IN VIVO EFFECTIVENESS AS ANTIMICROBIALS.
WHEREIN R is hydrogen or lower alkyl optionally substituted in the 2position by hydroxyl or by lower acyloxy or lower alkoxy; A is hydrogen, halogen, azido, cyano; lower alkyl, alkoxy, alkylthio, alkylsulfonyl, carboxyl; lower alkoxycarbonyl, lower alkoxycarbonimidoyl; or hydrazino, carbamoyl, amidino or a carboximidohydrazide group optionally substituted by one or two lower acyl, alkyl or cycloalkyl radicals; or A is a radical of the formula:
摘要:
2-Alkyl-4(3H)-pteridinone compounds of the formula
WHEREIN R is a straight-chain, branched or cyclic alkyl radical containing two to seven carbon atoms; AND THE SALTS THEREOF WITH PHYSIOLOGICALLY COMPATIBLE ACIDS AND BASES; ARE OUTSTANDINGLY EFFECTIVE IN DIURETIC AND NATRIURETIC ACTION.
摘要:
Highly stable cholesterol standard solution comprising a known amount of cholesterol together with 1 to 20 volume percent of a primary or secondary aliphatic alcohol containing up to 4 carbon atoms; 5 to 20 volume percent hydroxy-polyethoxydodecane or 40 to 60 volume percent diethyleneglycol monobutyl ether; and 0.5 to 5 weight percent sodium chloride and/or 0.01 to 0.5 weight percent alkyl dimethyl benzyl ammonium chloride with 8 to 18 carbon atoms in the alkyl radicals.
摘要:
WHEREIN X is a stabilizing anion; R1 and R2, which may be the same or different, are halogen or lower alkyl or alkoxy and R3 and R4, which may be the same or different, are hydrogen, halogen, nitro, or lower alkyl or alkoxy; THE AROMATIC RING IN FORMULA (I) containing either (a) 1 to 3 halogen atoms or (b) one nitro group, but not both together; and an amount of an acid sufficient for a coupling reaction between bilirubin and said diazonium salt.
Bilirubin, particularly as contained in body fluids, is determined with test strips comprising an absorbent
摘要翻译:特别是包含在体液中的胆红素由包含吸收剂的测试条确定,其中X是稳定的阴离子; R 1和R 2可以相同或不同,为卤素或低级烷基或烷氧基,R 3和R 4可以相同或不同,为氢,卤素,硝基或低级烷基或烷氧基; 式(I)中的芳族环(I)含有(a)1至3个卤素原子或(b)一个硝基,但不包括在一起; 以及一定量的足以用于胆红素与所述重氮盐之间的偶联反应的酸。
摘要:
Test strips are provided for detecting even small amounts of blood or other peroxidatively active substances in body fluids; the strips comprising a carrier containing a hydroperoxide, a chromogen, and as an activator, a compound of the formula WHEREIN R1 is a hydrogen atom or a methyl radical and benzene and/or pyridine rings are fused on at least one of the positions indicated with c, (d,e), f and g, provided that two adjacent rings must not simultaneously each contain a cyclic nitrogen atom, and wherein the aromatic compounds (1), apart from the positions indicated by H and R1, can be substituted by lower alkyl radicals which together can also form a hydroaromatic ring.
摘要翻译:提供测试条,用于检测体液中的少量血液或其他过氧化物质活性物质; 条带包含含有氢过氧化物,色原体和作为活化剂的载体,式WHEREIN R 1是氢原子或甲基,苯和/或吡啶环稠合在至少一个位置 c,(d,e),f和g,条件是两个相邻的环不能同时各自含有环状氮原子,并且其中芳族化合物(1)除了由H和R 1表示的位置可以被 低级烷基一起也可以形成一个水芳族环。
摘要:
Urobilinogens, optionally in the presence of bilirubin, are detected with a novel diagnostic agent comprising A. AT LEAST ONE STABLE DIAZONIUM SALT CONTAINING A PHENYL-, PYRROLE, OR PYRAZOLE RING ANNELLATED WITH AN AROMATIC SYSTEM IN A MESOMERIZABLE AND STERICALLY UNHINDERED POSITION OR SUBSTITUTED DIRECTLY OR VIA A VINYLENE RADICAL WITH AN AROMATIC SYSTEM, OR B. A PYRIDINE OR PYRAZOLE DIAZONIUM SALT SUBSTITUTED IN A MESOMERIZABLE POSITION WITH AT LEAST ONE POLYATOMIC ELECTRON DONOR GROUP HAVING AT LEAST ONE MESOMERIZABLE ELECTRON PAIR WITH THE PROVISO THAT THE SUM OF THE Hammett sigma values for all the substituents, and hetero atoms does not exceed the value of +0.6.
WHEREIN R1 IS ALKYL OF FROM 1 TO 6 CARBON ATOMS; AND R2 IS STRAIGHT-CHAINED OR BRANCHED ALKYL OF FROM 4 TO 10 CARBON ATOMS; CYCLOALKYL OR METHYLCYCLOALKYL WHEREIN THE CYCLOALKYL MOIETY CONTAINS FROM 3 TO 10 CARBON ATOMS, CYCLOALKYL-ALKYL WITH FROM 3 TO 10 CARBON ATOMS IN THE CYCLOALKYL GROUP AND FROM 1 TO 4 CARBON ATOMS IN THE ALKYL SIDE-CHAIN OR BICYCLOALKYL OF FROM 5 TO 7 CARBON ATOMS IN EACH RING; AND THE PHARMACOLOGICALLY COMPATIBLE SALTS THEREOF.
摘要:
ENZYMATICALLY REACTIVE SUBSTANCES CONTAINED IN AQUEOUS SOLUTIONS ARE QUANTITATIVELY DETERMINED BY INTRODUCING A DEFINED AMOUNT OF A SOLUTION SAMPLE CONTAINING THE SUBSTANCE TO BE DETERMINED AND WHICH IS FREE OF AIR BUBBLES, INTO A STREAM OF BUFFER SOLUTION IN A BLOCK-LIKE FASHION, WHEREIN THE BUFFER SOLUTION CONTAINS THE REAGENTS NECESSARY FOR AN ENZYMATIC REACTION WITH SAID SUBSTANCES AND FLOWS WITH CONSTANT VELOCITY AND WHEREIN THE INTRODUCTION OF THE BLOCK SAMPLE DOES NOT SUBSTANTIALLY ALTER THE VELOCITY OF FLOW, CONTACTING THE RESULTING STREAM WITH THE APPROPRIATE ENZYME AND THEN PASSING THE STREAM OVER A DETECTOR TO INDICATE THE AMOUNT OF REACTION HAVING OCCURED, AND RELATING READINGS FROM THE DETECTOR TO THE AMOUNT OF THE SUBSTANCE TO BE DETERMINED CONTAINED IN THE SAMPLE.
摘要:
CERTAIN NOVEL NITROFURAN COMPOUNDS OF THE FORMULA
R1-N(-R2)-C(-R3)=N-HET-CH=CH-C WHEREIN HET IS A NAPHTHYRIDINE OR S-TRIAZOLO (4,3-B)PYRIDAZINE SYSTEM AND THE R''S ARE VARIOUSLY DEFINED, WHICH ARE OUTSTANDINGLY EFFECTIVE BACTERIOSTATS AND BACTERICIDES.
WHEREIN R1 IS HYDROGEN ATOM OR A LOWER ALKYL; R2 IS LOWER ALKYL; R3 IS AN UNSUBSTITUTED OR SUBSTITUTED PHENYL OR BENZYL RADICAL, THE SUBSTITUENTS, WHEN PRESENT, BEING HALOGEN OR LOWER ALKYL OR ALKOXY GROUPS, AND N IS 1, 2 OR 3, AND THE PHARMACOLOGICALLY COMPATIBLE SALTS THEREOF; HAVE OUTSTANDING ANTI-OEDEMATOUS ACTIVITY AND REDUCE INCREASED CAPILLARY PERMEABILITY.